Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade Buy
- Symbol (CDMOP)
- Company Avid Bioservices, Inc.
- Price $25.06
- Changes Percentage (0.04%)
- Change $0.01
- Day Low $25.04
- Day High $25.07
- Year High $31.95
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.
- Last Earnings 03/05/2021
- Ex-Dividend for 5/16 Dividend 03/12/2021
- Dividend Payable 04/01/2021
- Today N/A
- Next Earnings (Estimated) N/A
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.00
- Trailing P/E Ratio -6265
- Forward P/E Ratio -6265
- P/E Growth -6265
- Net Income $-140,753,000
Income Statement
Quarterly
Annual
Latest News of CDMOP
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Avid Bioservices, Inc. (CDMO): This Small-Cap Healthcare Stock Is A Good Buy Right Now
Avid Bioservices, Inc. (NASDAQ:CDMO) is a top small-cap healthcare stock due to its growth in biopharmaceutical manufacturing. With 31 hedge fund holders and positive analyst sentiment, the stock is e...
By Yahoo! Finance | 1 month ago
